Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C

Clinical trial NCT05905926 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05905926
Sponsor: Ardelyx
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Irritable Bowel Syndrome With Constipation (IBS-C)

Start date: 2023-02-17
Primary completion: 2031-07-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.